Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
Caeregen Therapeutics Secures $1.4M Research Grant
Caeregen Therapeutics announced that it has received a $1.4 million Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) and National Eye Institute (NEI). The grant has been awarded to further the advancement of…
Alkem Laboratories Enters Ophthalmology Field
Alkem Laboratories has made its foray into the field of ophthalmology by introducing a comprehensive range of affordable and high-quality eye care products. This strategic expansion showcases Alkem’s dedication to innovation and commitment to meeting the diverse needs of patients…
Cellusion Secures $21 Million Funding
Cellusion, a Tokyo-based biotech company, announced the successful completion of its Series C Round financing, raising an impressive 2.83 billion yen, equivalent to $21 million. The primary focus of this funding is to accelerate the advancement of Cellusion’s lead program,…
VSY Biotechnology Achieved Strong Growth in Q1 2023
VSY Biotechnology GmbH is moving towards achieving its growth targets with incremental steps. The company’s General Manager, Andreas Kühnel, evaluated the impressive Q1 2023 results of the company in the following statement: “Our net sales in the first quarter of…
New Contact Lens to Prevent DED
A collaborative team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a contact lens prototype that is specifically designed to prevent contact lens-induced dry eye (CLIDE). The new lens helps treat this condition by enabling tear flow in…
What is optical coherence tomography
Optical coherence tomography (OCT) has been a cornerstone tool for many years for the diagnosis and management of conditions involving the posterior segment. Although continuous hardware and software advances have increased the applications and utility of OCT, multimodal imaging that…
A Next-Gen Monofocal IOL From Johnson & Johnson Vision
Johnson & Johnson Vision Announces Launch of TECNIS Eyhance™ Toric II IOL with TECNIS Simplicity™ Delivery System, a Next-Generation Monofocal Intraocular Lens for Cataracts Patients with Astigmatism, in Europe TECNIS Eyhance™ Toric II IOL offers all the benefits associated with…
J&J announced new products at the AAO annual meeting
Johnson & Johnson Vision announced a series of new products and innovations at the 2019 American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, CA, USA. The company announced the US Food & Drug Administration (FDA) approval of the…
VSY Biotech Signs Agreement With WAKAMOTO Pharma
Leinfelden – Echterdingen, Germany March 19, 2021, VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplementation in orthopedy and medical esthetics, announced today an agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. (hereinafter refer to…
HealthCare Royalty And Clearside Bio to Enter Into Agreement
Clearside Biomedical announced it has entered into an agreement with HealthCare Royalty Partners in a deal worth up to $65 million. The money received from the deal will be put to use by Clearside to fund the ongoing clinical testing…